ProPhase Labs effects 1-for-10 reverse stock split to meet Nasdaq listing requirements

ProPhase Labs, Inc.

Reverse stock split at 1-for-10 ratio effective December 2, 2025, approved by board and stockholders on November 30, 2025.
Post-split common shares outstanding approximately 5,768,951; trading symbol unchanged (PRPH).
Reverse stock split implemented to increase per-share price to meet continued Nasdaq listing requirements.
Fractional shares rounded up to nearest whole share; par value remains $0.0005 per share.
Certificate of Amendment filed with Delaware Secretary of State on December 2, 2025.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ProPhase Labs, Inc.: Amended Certificate of Incorporation to effect a 1-for-10 reverse stock split (effective 2025-12-02).

Change: charter amendment
Effective: 2025-12-02

Exact text from the filing

On November 30, 2025, the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the Company’s common stock at a ratio of one (1) shares for every ten (10) shares of common stock outstanding. The amendment became effective on December 2, 2025.

View on SEC.gov

Browse all governance changes →

ProPhase Labs, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-027317

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.